Page 3 - Accu Chek Guide News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Accu chek guide. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Accu Chek Guide Today - Breaking & Trending Today

F. Hoffmann-La Roche Ltd: [Ad hoc announcement pursuant to Art. 53 LR] Roche reports good half-year results

F. Hoffmann-La Roche Ltd: [Ad hoc announcement pursuant to Art. 53 LR] Roche reports good half-year results
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , Nathalie Meetz , Mabthera Rituxan , Gazyva Gazyvaro , Severin Schwan , Venclexta Venclyxto , Actemra Roactemra , Patrick Barth , Karsten Kleine , American Society Of Clinical Oncology , Pathology Lab , Pharma Division , European Commission , Diagnostics Division , International Region , Rxdx Panel , Molecular Lab , Core Lab , Pharmaceuticals Division , Roche Group , Pharmaceuticals Industry , Mark Diagnostics , Use Authorization , Excluding China , Middle East , North America ,

F. Hoffmann-La Roche Ltd: [Ad hoc-Mitteilung gemäss Art. 53 KR] Roche mit guten Halbjahresergebnissen

F. Hoffmann-La Roche Ltd: [Ad hoc-Mitteilung gemäss Art. 53 KR] Roche mit guten Halbjahresergebnissen
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , South Africa , Kwazulu Natal , Nathalie Meetz , Severin Swan , Applicationform Tecentriq , Immuntherapeutikum Tecentriq , Evrysdi Spinale , Roach Covid , Faricimab Diabetisches , Worldcom Drc , Patrick Barth , Diagnostics Division , Solutions For , Molecular Lab , Constant Exchange , Solutions In Connection , American Society Of Clinical Oncology New Data , Technology Of Genmark , University Of Oxford , Pathology Lab Regions , Development Of Drugs , Sales In The Diagnostics Division , Division Pharmaceutical Sales , Kundenbereiche Core Lab , Roach Ltd ,

Roche launches the mySugr® App in Thailand

Roche today announced that the mySugr app is now available in Thailand in English language. Users of mySugr can track relevant diabetes data wirelessly on their Apple or Android smartphones, supporting their daily diabetes management. In combination with the open ecosystem from Roche, the app enables data sharing capabilities and connects people with diabetes with their caregivers.
With a prevalence of 8.3% for the number of adults (20-79 years) with impaired glucose tolerance, Thailand is among the top ten countries in the world with the highest prevalence of diabetes in the world.[1] The mySugr app makes it quick and easy to collect relevant therapy data in one place through a growing number of connected devices, such as the Accu-Chek Guide or the Accu-Chek Instant blood glucose meters, and integrations with other solutions, such as Apple Health providing data-driven decision support for users. Some of its key features include a personalised logging screen, an estimated HbA1 ....

Mihai Irimescu , International Diabetes Foundation , Apple Health , Accu Chek Guide , Accu Chek Instant , Roche Diabetes Care , Rochediabetes Care Platform , Sugr Logbook , Atlas Ninth , சர்வதேச நீரிழிவு நோய் அடித்தளம் , ஆப்பிள் ஆரோக்கியம் , அச்சு கன்னம் வழிகாட்டி , அச்சு கன்னம் உடனடி , ரோச் நீரிழிவு நோய் பராமரிப்பு , அட்லஸ் ஒன்பதாவது ,

Roche reports solid results in the first quarter of 2021

Commenting on the Group’s performance in the first quarter, Roche CEO Severin Schwan said:
“In 2021, Roche remains strongly committed to the fight against COVID-19. The uptake of our recently introduced diagnostic tests and medicines remains strong, while we continue to see the expected
impact from biosimilars on sales of our established medicines. Our broad product pipeline keeps making good progress. I am particularly pleased about the highly encouraging study results of our
immunotherapy Tecentriq in early lung cancer and of faricimab in ophthalmology. The upcoming acquisition of GenMark underlines our commitment to help control infectious diseases and antibiotic
resistance. Based on the results of the first quarter of 2021, we confirm the outlook for the full year.” ....

United States , Nathalie Meetz , Daniel Grotzky , Actemra Roactemra , Mabthera Rituxan , Patrick Barth , Gazyva Gazyvaro , Karsten Kleine , Pathology Lab , European Commission , Diagnostics Division , International Region , Molecular Lab , Core Lab , Pharmaceuticals Division , Roche Group , Pharmaceuticals Industry , Roche Group Media Relations , Elecsysepstein Barr Virus , Breakthrough Device Designation , Eastern Europe , Middle East , Latin America , Accu Chek Guide , Rochediabetes Care Platform , World Health Organization Model Lists ,

F. Hoffmann-La Roche Ltd: Roche reports solid results in the first quarter of 2021

F. Hoffmann-La Roche Ltd: Roche reports solid results in the first quarter of 2021
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , Nathalie Meetz , Daniel Grotzky , Mabthera Rituxan , Gazyva Gazyvaro , Severin Schwan , Actemra Roactemra , Patrick Barth , Karsten Kleine , Pathology Lab , European Commission , Diagnostics Division , International Region , Molecular Lab , Core Lab , Pharmaceuticals Division , Pharmaceuticals Industry , Roche Group Media Relations , Antigen Test Nasal , Eastern Europe , Middle East , Latin America , North America , Genmark Diagnostics , Elecsys Epstein Barr Virus , Elecsys Anti P ,